[1] |
ABDEL-RAZEK HA, RIZK MS, AMER GS, et al. Impact of combined ischemic preconditioning and melatonin on renal ischemia-reperfusion injury in rats[J]. Iran J Basic Med Sci, 2023, 26(2): 235-240. DOI: 10.22038/IJBMS.2022.67127.14722.
|
[2] |
HUANG D, CHEN D, HU T, et al. GATA2 promotes oxidative stress to aggravate renal ischemia-reperfusion injury by up-regulating Redd1[J]. Mol Immunol, 2023, 153: 75-84. DOI: 10.1016/j.molimm.2022.09.012.
|
[3] |
ZHANG B, WAN S, LIU H, et al. Naringenin alleviates renal ischemia reperfusion injury by suppressing ER stress-induced pyroptosis and apoptosis through activating Nrf2/HO-1 signaling pathway[J]. Oxid Med Cell Longev, 2022: 5992436. DOI: 10.1155/2022/5992436.
|
[4] |
LAU A, RAHN JJ, CHAPPELLAZ M, et al. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury[J]. Sci Adv, 2022, 8(5): eabm0142. DOI: 10.1126/sciadv.abm0142.
|
[5] |
LI T, SUN H, LI Y, et al. Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI[J]. Cell Death Discov, 2022, 8(1): 61. DOI: 10.1038/s41420-022-00859-z.
|
[6] |
LAN TY, DUN RL, YAO DS, et al. Effects of resveratrol on renal ischemia-reperfusion injury: a systematic review and meta-analysis[J]. Front Nutr, 2023, 9: 1064507. DOI: 10.3389/fnut.2022.1064507.
|
[7] |
LUO Y, ZHU J, ZHAO F, et al. PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38[J]. Int Immunopharmacol, 2023, 114: 109563. DOI: 10.1016/j.intimp.2022.109563.
|
[8] |
GUO R, WANG H, CUI N. Autophagy regulation on pyroptosis: mechanism and medical implication in sepsis[J]. Mediators Inflamm, 2021: 9925059. DOI: 10.1155/2021/9925059.
|
[9] |
韩明伟, 马瑞雪, 刘梓谕, 等. 炎性小体在炎症性疾病中的研究进展[J]. 转化医学杂志, 2021, 10(2): 116-120. DOI: 10.3969/j.issn.2095-3097.2021.02.012.HAN MW, MA RX, LIU ZY, et al. Research progress of inflammasomes in inflammatory diseases[J]. Transl Med J, 2021, 10(2): 116-120. DOI: 10.3969/j.issn.2095-3097.2021.02.012.
|
[10] |
HAN B, XU J, SHI X, et al. Dl-3-N-butylphthalide attenuates myocardial hypertrophy by targeting Gasdermin D and inhibiting Gasdermin D mediated inflammation[J]. Front Pharmacol, 2021, 12: 688140. DOI: 10.3389/fphar.2021.688140.
|
[11] |
肖海燕, 杨淑贤, 韩雯, 等. 丁苯酞及其衍生物药理学研究进展[J]. 中国中药杂志, 2022, 47(13): 3425-3431. DOI: 10.19540/j.cnki.cjcmm.20220117.701.XIAO HY, YANG SX, HAN W, et al. Research progress on pharmacology of butylphthalide and its derivatives[J]. China J Chin Mater Med, 2022, 47(13): 3425-3431. DOI: 10.19540/j.cnki.cjcmm.20220117.701.
|
[12] |
DONG Y, YIN J, CHEN T, et al. Dl-3-N-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury[J]. Biochem Biophys Res Commun, 2021, 557: 166-173. DOI: 10.1016/j.bbrc.2021.04.006.
|
[13] |
HUANG Y, PAN L, WU T. Improvement of cerebral ischemia-reperfusion injury by L-3-N-butylphthalide through promoting angiogenesis[J]. Exp Brain Res, 2021, 239(1): 341-350. DOI: 10.1007/s00221-020-05978-6.
|
[14] |
SHAN HUANG S, ZHOU B, XIAN ZENG G, et al. Neuroprotective effect and mechanism of butylphthalide after cerebral ischemia-reperfusion injury in rats[J]. Folia Neuropathol, 2021, 59(2): 131-142. DOI: 10.5114/fn.2021.107667.
|
[15] |
ZHANG D, ZHENG N, FU X, et al. Dl-3-N-butylphthalide attenuates myocardial ischemia reperfusion injury by suppressing oxidative stress and regulating cardiac mitophagy via the PINK1/Parkin pathway in rats[J]. J Thorac Dis, 2022, 14(5): 1651-1662. DOI: 10.21037/jtd-22-585.
|
[16] |
XIA W, LI Y, WU M, et al. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation[J]. Cell Death Dis, 2021, 12(2): 139. DOI: 10.1038/s41419-021-03431-2.
|
[17] |
NA SW, JANG YJ, HONG MH, et al. Protective effect of joa-gui em through the improvement of the NLRP3 and TLR4/NF-κB signaling by ischemia/reperfusion-induced acute renal failure rats[J]. Evid Based Complement Alternat Med, 2021: 7178868. DOI: 10.1155/2021/7178868.
|
[18] |
马卓奇, 敖娜, 杨楠, 等. NLRP3炎性小体与非酒精性脂肪性肝病的相关性及利拉鲁肽对其的影响[J]. 中华肝脏病杂志, 2022, 30(6): 624-630. DOI: 10.3760/cma.j.cn501113-20200326-00142.MA ZQ, AO N, YANG N, et al. Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease[J]. Chin J Hepatol, 2022, 30(6): 624-630. DOI: 10.3760/cma.j.cn501113-20200326-00142.
|
[19] |
CAI Q, SUN Z, XU S, et al. Disulfiram ameliorates ischemia/reperfusion-induced acute kidney injury by suppressing the Caspase-11-GSDMD pathway[J]. Ren Fail, 2022, 44(1): 1169-1181. DOI: 10.1080/0886022X.2022.2098764.
|
[20] |
YIN F, ZHENG PQ, ZHAO LQ, et al. Caspase-11 promotes NLRP3 inflammasome activation via the cleavage of pannexin1 in acute kidney disease[J]. Acta Pharmacol Sin, 2022, 43(1): 86-95. DOI: 10.1038/s41401-021-00619-2.
|
[21] |
张瑞波, 申开文, 袁强, 等. NF-κB相关信号通路在肾缺血-再灌注损伤中作用的研究进展[J]. 器官移植, 2022, 13(3): 349-355. DOI: 10.3969/j.issn.1674-7445.2022.03.011.ZHANG RB, SHEN KW, YUAN Q, et al. Research progress of NF-κB signaling pathway in kidney ischemia-reperfusion injury[J]. Organ Transplant, 2022, 13(3): 349-355. DOI: 10.3969/j.issn.1674-7445.2022.03.011.
|
[22] |
SU X, LIU B, WANG S, et al. NLRP3 inflammasome: a potential therapeutic target to minimize renal ischemia/reperfusion injury during transplantation[J]. Transpl Immunol, 2022, 75: 101718. DOI: 10.1016/j.trim.2022.101718.
|
[23] |
袁强, 申开文, 张瑞波, 等. NLRP3炎症小体与相关炎症信号通路在肾缺血-再灌注损伤中的作用[J]. 器官移植, 2021, 12(2): 177-183. DOI: 10.3969/j.issn.1674-7445.2021.02.007.YUAN Q, SHEN KW, ZHANG RB, et al. Role of NLRP3 inflammasome and related inflammatory signaling pathways in renal ischemia-reperfusion injury[J]. Organ Transplant, 2021, 12(2): 177-183. DOI: 10.3969/j.issn.1674-7445.2021.02.007.
|
[24] |
PANG Y, ZHANG PC, LU RR, et al. Andrade-oliveira salvianolic acid B modulates caspase-1-mediated pyroptosis in renal ischemia-reperfusion injury via Nrf2 pathway[J]. Front Pharmacol, 2020, 11: 541426. DOI: 10.3389/fphar.2020.541426.
|
[25] |
LIU JJ, LU L, HU FQ, et al. Methylene blue attenuates renal ischemia-reperfusion injury by negative regulation of NLRP3 signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22(9): 2847-2853. DOI: 10.26355/eurrev_201805_14986.
|
[26] |
SHIN JH, KIM SS, SEO SR. Pyrrolidine dithiocarbamate suppresses cutibacterium acnes-induced skin inflammation[J]. Int J Mol Sci, 2023, 24(5): 4444. DOI: 10.3390/ijms24054444.
|
[27] |
XU J, LI S, YANG X, et al. Mechanism of nonylphenol induced gastric inflammation through NF-κB/NLRP3 signaling pathway[J]. Toxicology, 2022, 479: 153294. DOI: 10.1016/j.tox.2022.153294.
|
[28] |
YU Y, ZHU Y, SUN X, et al. Dl-3-N-butylphthalide protects H9c2 cardiomyoblasts from ischemia/reperfusion injury by regulating HSP70 expression via PI3K/Akt pathway activation[J]. Exp Ther Med, 2021, 22(3): 1008. DOI: 10.3892/etm.2021.10441.
|
[29] |
LIU CY, ZHAO ZH, CHEN ZT, et al. Dl-3-N-butylphthalide protects endothelial cells against advanced glycation end product-induced injury by attenuating oxidative stress and inflammation responses[J]. Exp Ther Med, 2017, 14(3): 2241-2248. DOI: 10.3892/etm.2017.4784.
|
[30] |
LIAO D, XIANG D, DANG R, et al. Neuroprotective effects of dl-3-N-butylphthalide against doxorubicin-induced neuroinflammation, oxidative stress, endoplasmic reticulum stress, and behavioral changes[J]. Oxid Med Cell Longev, 2018: 9125601. DOI: 10.1155/2018/9125601.
|
[31] |
HAN J, SHI X, XU J, et al. Dl-3-N-butylphthalide prevents oxidative stress and atherosclerosis by targeting Keap-1 and inhibiting Keap-1/Nrf-2 interaction[J]. Eur J Pharm Sci, 2022, 172: 106164. DOI: 10.1016/j.ejps.2022.106164.
|
[32] |
ZHAO S, LIU F, SHI W, et al. Dl-3-N-butylphthalide promotes hippocampal neurogenesis and reduces mossy fiber sprouting in chronic temporal lobe epilepsy rats[J]. BMC Neurol, 2022, 22(1): 3. DOI: 10.1186/s12883-021-02516-x.
|
[33] |
GAO L, GUO X, LIU S, et al. Dl-3-N-butylphthalide imparts neuroprotection via Nrf2/SIRT3 pathway in a mouse model of vascular dementia[J]. Brain Res, 2022, 1779: 147785. DOI: 10.1016/j.brainres.2022.147785.
|
[34] |
WANG J, LI Y, YU H, et al. Dl-3-N-butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in C57BL/6 mice[J]. Front Pharmacol, 2021, 12: 751397. DOI: 10.3389/fphar.2021.751397.
|
[35] |
SUN H, WANG J, BI W, et al. Dl-3-N-butylphthalide (NBP) mitigates muscular injury induced by limb ischemia/reperfusion in mice through the HMGB1/TLR4/NF-κB pathway[J]. Evid Based Complement Alternat Med, 2022: 5556067. DOI: 10.1155/2022/5556067.
|